Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mereo BioPharma
With
Novartis
Age
18–49
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Must have surgical diagnosis of endometriosis est. w/in 5 years before screening. Subjects must have self reported moderate to severe pelvic pain at screening to be confirmed during the run-in-phase
Subjects with moderate to severe pelvic pain who were refractory to surgery (persistent or recurrent pelvic pain within 24 months after any therapeutic surgery) and at least two hormonal therapies from two different classes, including one approved hormonal therapy
You may not be if
Subjects who have undergone hysterectomy or bilateral oophorectomy.
Surgical treatment of endometriosis within 3 months before screening.
Subjects who are pregnant or who were pregnant within 3 months of visit one.
